Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Benson AB 3rd, Venook AP, Cederquist L, et al. Colon Cancer, Version 1. 2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(3):370–98.

    Article  CAS  Google Scholar 

  2. Dercle L, Lu L, Schwartz LH, et al. Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway. J Natl Cancer Inst. 2020;112(9):902–12.

    Article  Google Scholar 

  3. Ahn SJ, Kim JH, Park SJ, Han JK. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol. 2016;85(10):1867–74.

    Article  Google Scholar 

  4. Nakanishi R, Oki E, Hasuda H, Sano E, Miyashita Y, Sakai A. Radiomics texture analysis for the identification of colorectal liver metastases sensitive to first-line oxaliplatin-based chemotherapy. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09581-5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan

    Ryota Nakanishi MD, PhD, Eiji Oki MD, PhD, Hirofumi Hasuda MD, Eiki Sano MD, Yu Miyashita MD, Akihiro Sakai MD, Naomichi Koga MD, Naotaka Kuriyama MD, Kentaro Nonaka MD, Yoshiaki Fujimoto MD, Tomoko Jogo MD, Kentaro Hokonohara MD, PhD, Qingjiang Hu MD, PhD, Yuichi Hisamatsu MD, PhD, Koji Ando MD, PhD, Yasue Kimura MD, PhD, Tomoharu Yoshizumi MD, PhD & Masaki Mori MD, PhD

Authors
  1. Ryota Nakanishi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Oki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirofumi Hasuda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eiki Sano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu Miyashita MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akihiro Sakai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Naomichi Koga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Naotaka Kuriyama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kentaro Nonaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yoshiaki Fujimoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tomoko Jogo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kentaro Hokonohara MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Qingjiang Hu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yuichi Hisamatsu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Koji Ando MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Yasue Kimura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Tomoharu Yoshizumi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Masaki Mori MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryota Nakanishi MD, PhD.

Ethics declarations

Disclosures

Eiji Oki has received honoraria for lecturing from Taiho Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd, Bayer, Eli Lilly, Takeda Pharmaceutical Co., Ltd, and Chugai Pharmaceutical Co., Ltd. Ryota Nakanishi, Hirofumi Hasuda, Eiki Sano, Yu Miyashita, Akihiro Sakai, Naomichi Koga, Naotaka Kuriyama, Kentaro Nonaka, Yoshiaki Fujimoto, Tomoko Jogo, Kentaro Hokonohara, Qingjiang Hu, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Tomoharu Yoshizumi, and Masaki Mori have no disclosures to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakanishi, R., Oki, E., Hasuda, H. et al. ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis. Ann Surg Oncol 28, 2986–2987 (2021). https://doi.org/10.1245/s10434-020-09584-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09584-2

Search

Navigation